Searchable abstracts of presentations at key conferences in endocrinology

ea0011p154 | Clinical case reports | ECE2006

Endocrine disorders in a high secure hospital

Macfarlane IA , Deepak D , Gill GV

Objectives: To audit the endocrine referrals from a High Secure Hospital (HSH) to a department of endocrinology.Methods: During the study, the HSH had approximately 400 beds, 75% male, 75% mental illness (mostly schizophrenia), 25% psychopathic personality disorders. The average length of stay in the HSH was 8 years, the majority of patients receive antipsychotic drugs (APD) and obesity and cigarette smoking is common.Results: Over...

ea0009p101 | Endocrine tumours and neoplasia | BES2005

Patients with hypothalamic-pituitary disease: prevalence of diabetes, hypertension, dyslipidemia and other cardio-vascular risk factors

Furlong N , Deepak D , MacFarlane I

Several studies suggest that mortality rates due to cardiovascular disease (CVD) are increased in patients with hypopituitarism. We retrospectively assessed the prevalence of known diabetes, treated hypertension and dyslipidemia, known risk factors for cardiovascular disease (CVD), in a large population (n:250) of patients with hypothalamic-pituitary disease. We then prospectively screened 90 such patients for the following CVD risk factors: obesity, diabetes mellitus, smoking...

ea0009p204 | Clinical | BES2005

Langerhans cell histiocytosis and auto-immune thyroiditis presenting as a thyroid mass with progressive hypothalamic-pituitary dysfunction

Deepak D , Woodcock B , MacFarlane I

A 53 year old woman developed a firm thyroid mass which was removed. The histology of the thyroid mass showed auto-immune thyroiditis and Langerhans cell Histiocytosis ( LCH). She also complained of thirst and polyuria. A water deprivation test confirmed cranial diabetes inspidus (CDI) ,the symptoms of which resolved on DDAVP . A glucagon stimulation test showed a blunted growth hormone (GH) response of 13.3 milliU per litre with an IGF-1 level of 16 nanomol per litre. The cor...

ea0011p136 | Clinical case reports | ECE2006

Epilepsy at presentation of macroprolactinoma

Deepak D , Bashir N , Foy P , Macfarlane IA

Objectives: Prolactinomas can extend out of the sella turcica and invade surrounding structures and the brain. The prevalence and natural history of epilepsy at presentation of macroprolactinoma is not clear.Methods: The case records of 62 patients (34 male) with macroprolactinoma attending a neuroendocrine clinic were studied.Results: Four patients (6.5%, 3 males) had experienced epileptic seizures before the diagnosis of macropro...

ea0011p622 | Neuroendocrinology and behaviour | ECE2006

The influence of growth hormone replacement (GHR) in adults with GH deficiency (GHD) on body composition, basal metabolic rate, physical activity and ingestive behaviour

Deepak D , Daousi C , Wilding JP , Pinkney J , Macfarlane IA

Objectives: GHR in adults with GHD favourably effects body composition (reduces fat and increases lean body mass) although body weight usually remains unchanged. However the effect of GHR on ingestive behaviour and voluntary physical activity in adults has not been studied.Methods: We studied 10 hypopituitary adults (8 males, 2 females, mean age 49.7 years) with severe GHD (mean peak GH response to glucagon 3.26 mU/l, baseline IGF-1 level 14.5 nmol/L) be...